Skip to main content
. 2023 May 22;15(5):2729–2741. doi: 10.21037/jtd-23-305

Table 1. Clinicopathological characteristics of patients.

Characteristics IBG (N=67) RG (N=997) P value
Gender 0.995
   Female 37 (55.22) 551 (55.27)
   Male 30 (44.78) 446 (44.73)
Age 0.126
   <60 years 25 (37.31) 468 (46.94)
   ≥60 years 42 (62.69) 529 (53.06)
Smoke 0.428
   No 38 (56.72) 614 (61.58)
   Yes 29 (43.28) 383 (38.42)
History of chest disease 0.348
   No 60 (89.55) 924 (92.68)
   Yes 7 (10.45) 73 (7.32)
History of chest surgery <0.001*
   No 60 (89.55) 974 (97.69)
   Yes 7 (10.45) 23 (2.31)
Neoadjuvant therapy 0.366
   No 60 (89.55) 923 (92.58)
   Yes 7 (10.45) 74 (9.42)
Anticoagulant therapy 0.109
   No 63 (94.03) 976 (97.89)
   Yes 4 (5.97) 21 (2.11)
Position of tumor 0.105
   Central type 13 (19.40) 125 (12.84)
   Peripheral type 54 (80.60) 872 (87.46)
Location of tumor 0.094
   Left 33 (49.25) 388 (38.92)
   Right 34 (50.75) 609 (61.08)
Pleural adhesion 0.015*
   No 44 (65.67) 782 (78.43)
   Yes 23 (34.33) 215 (21.56)
Pathological type 0.034*
   Squamous 16 (23.88) 143 (14.34)
   Non-squamous 51 (76.12) 854 (85.66)
T stage 0.003*
   Tis–T1 35 (52.24) 697 (69.91)
   T2-4 32 (47.76) 300 (30.09)
N stage 0.187
   N0 48 (71.64) 783 (78.54)
   N1–2 19 (28.36) 214 (21.46)

Data are expressed as n (%). *, P<0.05. IBG, intraoperative bleeding group; RG, reference group.